Although some LXR targets in mice are not conserved in humans, these results revealed that LXRα promoted cholesterol transport from the liver to bile and gallstone formation by upregulating ABCG5 and ABCG8 expression levels, which might provide a new direction in the treatment of gallstones. The gene discussed is ABCG8; the disease is gallstones.